Literature DB >> 22911956

Risk factors for premature myocardial infarction: a matched case-control study.

Tooba Kazemi1, Gholam Reza Sharifzadeh, Asghar Zarban, Azita Fesharakinia, Mohamad Reza Rezvani, Seyed Ali Moezy.   

Abstract

BACKGROUND: Myocardial infarction in young age is increasing. Identifying risk factors could be important for health promotion. We studied classic atherosclerotic risk factors in premature myocardial infarction.
METHODS: In this matched case-control study, which was conducted from 2005 to 2007 in Birjand County, the east of Iran, atherosclerotic risk factors (hyperten-sion, family history of coronary artery diseases, obesity, diabetes mellitus, dyslipidemia) of 98 patients affected by acute myocardial infarction aged under 50 years were compared with that of 98 healthy neighborhood controls.
RESULTS: Mean levels of cholesterol, triglyceride, low-density lipoprotein, as well as systolic blood pressure and body mass index were significantly higher in cases than in controls. There was a positive association between coronary artery disease at younger age and dyslipidemia OR=2.8 [95% CI: 1.5, 5.2], smoking OR=6.4 [95% CI: 3.0, 13.5], systolic hypertension OR=3.1 [95% CI: 1.5, 6.3], family history of coronary artery diseases OR=10.9 [95% CI: 3.2, 37.9] and diabetes OR=2.5 [95% CI: 1.04, 6.2].
CONCLUSION: Smoking, systolic hypertension and dyslipidemia were the most common risk factors among patients with premature myocardial infarction.

Entities:  

Year:  2011        PMID: 22911956

Source DB:  PubMed          Journal:  J Res Health Sci        ISSN: 2228-7795


  14 in total

1.  Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case -control study.

Authors:  Toba Kazemi; Gholamreza Sharifzadeh; Asghar Zarban; Azita Fesharakinia
Journal:  Int J Prev Med       Date:  2013-01

2.  Perinatal risk factors for premature ischaemic heart disease in a Swedish national cohort.

Authors:  Bengt Zöller; Jan Sundquist; Kristina Sundquist; Casey Crump
Journal:  BMJ Open       Date:  2015-06-02       Impact factor: 2.692

3.  The Prevalence of Diabetes and Prediabetes Among Elementary School Children in Birjand.

Authors:  Tayyebeh Chahkandi; Fatemeh Taheri; Toba Kazemi; Bita Bijari
Journal:  Iran J Pediatr       Date:  2015-02-15       Impact factor: 0.364

4.  Different patterns of association between education and wealth with non-fatal myocardial infarction in Tehran, Iran: A population-based case-control study.

Authors:  Bahman Cheraghian; Saharnaz Nedjat; Mohammad Ali Mansournia; Reza Majdzadeh; Kazem Mohammad; Mohammad Reza Vaez-Mahdavi; Soghrat Faghihzadeh; Ali Asghar Haeri Mehrizi; Mohsen Asadi-Lari
Journal:  Med J Islam Repub Iran       Date:  2015-01-13

Review 5.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

Review 6.  A Systematic Review on the Prevalence of Acute Myocardial Infarction in Iran.

Authors:  Jaber Mohseni; Toba Kazemi; Mahmood Hosseinzadeh Maleki; Hossein Beydokhti
Journal:  Heart Views       Date:  2017 Oct-Dec

7.  Comparison of Carotid Intima-media Thickness in Hypertensive Patients and Control Group.

Authors:  Ghodratollah Naseh; Mahyar Mohammadi Fard; Toba Kazemi; AliReza Mirgholami; Narges Hashemi; Amin Saburi
Journal:  J Cardiovasc Echogr       Date:  2016 Apr-Jun

8.  Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran.

Authors:  Toba Kazemi; Morteza Hajihosseini; Maryam Moossavi; Mina Hemmati; Masood Ziaee
Journal:  Clin Med Insights Cardiol       Date:  2018-02-20

9.  A memorandum of "world heart day 2012": myocardial infarction mortality in women in birjand, 2008-2009.

Authors:  Toba Kazemi; Gholam Reza Sharifzadeh
Journal:  J Tehran Heart Cent       Date:  2012-11-30

10.  The Efficacy of Crocin of Saffron (Crocus sativus L.) on the Components of Metabolic Syndrome: A Randomized Controlled Clinical Trial.

Authors:  Tayyebe Kermani; Toba Kazemi; Somayye Molki; Khadije Ilkhani; Gholamreza Sharifzadeh; Omid Rajabi
Journal:  J Res Pharm Pract       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.